REFILE-FACTBOX-Vaccines delivered under COVAX vaccine-sharing scheme

U.S. Regulatory News

Reuters Staff

 (Refiles March 26 story to fix headline and date)
	    March 26 (Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and
	the Global Alliance for Vaccines and Immunization (GAVI), aims to secure 2 billion vaccine doses
	for lower income countries by the end of 2021.
	    In early March, it said the target was to deliver 237 million doses of AstraZeneca's
	shot to 142 countries by the end of May, and it also shipped its first Pfizer shots.
	
	    The following tables list the countries that have received vaccines under the scheme, sorted
	by region and delivery date:
	
	    AFRICA & MIDDLE EAST
	 COUNTRY            LATEST        DATE         VACCINE TYPE        POPULATION    TOTAL
	                    DELIVERY                                                     DELIVERED
	 Ghana              600,000       Feb. 24      AstraZeneca/Oxford  30 million    600,000
	 Ivory Coast        504,000       Feb. 26      AstraZeneca/Oxford  26 million    504,000
	 Nigeria            3.9 million   March 2      AstraZeneca/Oxford  201 million   3.9 million
	 Democratic         1.7 million   March 2      AstraZeneca/Oxford  87 million    1.7 million
	 Republic of Congo                                                               
	 Angola             624,000       March 2      AstraZeneca/Oxford  32 million    624,000
	 Gambia             36,000        March 2      AstraZeneca/Oxford  2.3 million   36,000
	 Senegal            324,000       March 3      AstraZeneca/Oxford  16 million    324,000
	 Kenya              1 million     March 3      AstraZeneca/Oxford  53 million    1 million
	 Rwanda             240,000       March 3      AstraZeneca/Oxford  13 million    342,920
	                    102,960                    Pfizer BioNTech                   
	 Sudan              828,000       March 3      AstraZeneca/Oxford  43 million    828,000
	 Sao Tome and       24,000        March 3      AstraZeneca/Oxford  215,000       24,000
	 Principe                                                                        
	 Lesotho            36,000        March 3      AstraZeneca/Oxford  2.1 million   36,000
	 Mali               396,000       March 4      AstraZeneca/Oxford  20 million    396,000
	 Uganda             864,000       March 5      AstraZeneca/Oxford  44 million    864,000
	 Malawi             360,000       March 5      AstraZeneca/Oxford  19 million    360,000
	 Liberia            96,000        March 5      AstraZeneca/Oxford  4.9 million   96,000
	 Djibouti           24,000        March 6      AstraZeneca/Oxford  990,000       24,000
	 Ethiopia           2.2 million   March 7      AstraZeneca/Oxford  112 million   2.2 million
	 Togo               156,000       March 8      AstraZeneca/Oxford  8.1 million   156,000
	 Mozambique         384,000       March 8      AstraZeneca/Oxford  30 million    384,000
	 Sierra Leone       96,000        March 8      AstraZeneca/Oxford  7.8 million   96,000
	 Benin              144,000       March 10     AstraZeneca/Oxford  12 million    144,000
	 Cabo Verde         24,000        March 12     AstraZeneca/Oxford  540,000       24,000
	 Jordan             144,000       March 12     AstraZeneca/Oxford  10 million    144,000
	 Eswatini           12,000        March 13     AstraZeneca/Oxford  1.1 million   12,000
	 Somalia            300,000       March 15     AstraZeneca/Oxford  15 million    300,000
	 Palestinian        24,000        March 17     AstraZeneca/Oxford  4.7 million   61,440
	 Territories        37,440                     Pfizer BioNTech                   
	 Tunisia            93,600        March 17     Pfizer BioNTech     12 million    93,600
	 Lebanon            33,600        March 24     AstraZeneca/Oxford  6.9 million   33,600
	 South Sudan        132,000       March 25     AstraZeneca/Oxford  11 million    132,000
	 Iraq               336,000       March 25     AstraZeneca/Oxford  39.3 million  336,000
	 
	    EUROPE
	 COUNTRY      LATEST        DATE        VACCINE TYPE            POPULATION     TOTAL
	              DELIVERY                                                         DELIVERED
	 Moldova      14,400        March 4     N/A                     2.7 million    14,400
	 Albania      38,400        March 12    AstraZeneca/Oxford      2.9 million    38,400
	 Georgia      43,200        March 13    AstraZeneca/Oxford      3.7 million    43,200
	 Bosnia       23,400        March 25    Pfizer BioNTech         3.3 million    49,800
	              26,400                    AstraZeneca/Oxford                     
	 
	    ASIA & PACIFIC
	 COUNTRY      LATEST       DATE        VACCINE TYPE            POPULATION      TOTAL
	              DELIVERY                                                         DELIVERED
	 Cambodia     324,000      March 2     AstraZeneca/Oxford      16 million      324,000
	 Philippines  487,200      March 4     AstraZeneca/Oxford      108 million     487,200
	 Fiji         12,000       March 6     AstraZeneca/Oxford      900,000         12,000
	 Nepal        348,000      March 7     AstraZeneca/Oxford      29 million      348,000
	 Maldives     12,000       March 7     AstraZeneca/Oxford      531,000         12,000
	 Sri Lanka    264,000      March 7     AstraZeneca/Oxford      22 million      264,000
	 Indonesia    1.1 million  March 8     AstraZeneca/Oxford      271 million     1.1 million
	 Afghanistan  468,000      March 8     AstraZeneca/Oxford      38 million      468,000
	 Tajikistan   192,000      March 9     AstraZeneca/Oxford      9.3 million     192,000
	                                                                               
	 Uzbekistan   660,000      March 17    AstraZeneca/Oxford      34 million      660,000
	 Solomon      24,000       March 19    AstraZeneca/Oxford      670,000         24,000
	 Islands                                                                       
	 Laos         132,000      March 20    AstraZeneca/Oxford      7.2 million     132,000
	 Mongolia     25,700       March 25    AstraZeneca/Oxford      3.2 million     40,100
	                                       Pfizer BioNTech                         
	 
	    AMERICAS
	 COUNTRY      LATEST      DATE         VACCINE TYPE            POPULATION       TOTAL
	              DELIVERY                                                          DELIVERED
	 Peru         117,000     March 10     Pfizer/BioNTech         33 million       117,000
	 Guatemala    81,600      March 11     AstraZeneca/Oxford      17 million       81,600
	                                                                                
	 Honduras     48,000      March 13     AstraZeneca/Oxford      9.7 million      48,000
	 Jamaica      14,400      March 15     AstraZeneca/Oxford      2.9 million      14,400
	 Nicaragua    135,000     March 16     AstraZeneca/Oxford      6.5 million      135,000
	 Ecuador      84,000      March 17     AstraZeneca/Oxford      17 million       84,000
	 Paraguay     36,000      March 19     AstraZeneca/Oxford      7.0 million      36,000
	 Colombia     244,800     March 20     AstraZeneca/Oxford      50 million       361,800
	 Brazil       1 million   March 21     AstraZeneca/Oxford      214 million      1 million
	 Bolivia      228,000     March 21     AstraZeneca/Oxford      12 million       228,000
	 El Salvador  51,480      March 22     Pfizer/BioNTech         6.5 million      85,000
	 
	    Sources: Reuters news reports, WHO, UNICEF, GAVI
	
	    
	 (Reporting by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki and Antonis Triantafyllou in
	Gdansk; Editing by Milla Nissi and Tomasz Janowski)